Literature DB >> 9880471

Genital herpes: review of the epidemic and potential use of type-specific serology.

R L Ashley1, A Wald.   

Abstract

Prevention of genital herpes simplex virus (HSV) infections is desirable from both a public health standpoint and the patient's perspective. A key factor in the spread of genital herpes infections is the high proportion of undiagnosed infections. Persons with subclinical or unrecognized infections are best diagnosed by accurate, type-specific antibody tests. Unfortunately, these tests are only now becoming widely available. The use of current, conventional (non-type-specific) serologic tests for diagnosis of herpes infections has resulted in confusion and misdiagnosis of patients. This review provides recent information on the epidemiology of genital herpes infections, describes the importance of subclinical herpes infection and shedding, summarizes the status of HSV type-specific serologic assays being developed, and provides indications for using such assays.

Entities:  

Mesh:

Year:  1999        PMID: 9880471      PMCID: PMC88903          DOI: 10.1128/CMR.12.1.1

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  74 in total

1.  A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls.

Authors:  B Christenson; M Böttiger; A Svensson; S Jeansson
Journal:  J Infect       Date:  1992-09       Impact factor: 6.072

Review 2.  The management of pregnancies complicated by genital infections with herpes simplex virus.

Authors:  C G Prober; L Corey; Z A Brown; P A Hensleigh; L M Frenkel; Y J Bryson; R J Whitley; A M Arvin
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

3.  Hepatitis due to herpes simplex virus in marrow-transplant recipients.

Authors:  J R Johnson; S Egaas; C A Gleaves; R Hackman; R A Bowden
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2.

Authors:  F D Boucher; L L Yasukawa; K Kerns; M Kastelein; A M Arvin; C G Prober
Journal:  Clin Diagn Virol       Date:  1993-03

Review 5.  Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.

Authors:  S Safrin
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

6.  Risk factors for the sexual transmission of genital herpes.

Authors:  G J Mertz; J Benedetti; R Ashley; S A Selke; L Corey
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

7.  Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals.

Authors:  E W Hook; R O Cannon; A J Nahmias; F F Lee; C H Campbell; D Glasser; T C Quinn
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

8.  Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2).

Authors:  D W Ho; P R Field; E Sjögren-Jansson; S Jeansson; A L Cunningham
Journal:  J Virol Methods       Date:  1992-03       Impact factor: 2.014

9.  Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.

Authors:  D M Koelle; J Benedetti; A Langenberg; L Corey
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

10.  Underdiagnosis of genital herpes by current clinical and viral-isolation procedures.

Authors:  L A Koutsky; C E Stevens; K K Holmes; R L Ashley; N B Kiviat; C W Critchlow; L Corey
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

View more
  44 in total

1.  Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors:  H E Prince; C E Ernst; W R Hogrefe
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.

Authors:  B Ohana; M Lipson; N Vered; I Srugo; M Ahdut; A Morag
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 3.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

4.  Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

5.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

6.  Genital herpes.

Authors:  A M Geretti
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

7.  Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors:  Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

8.  The laboratory diagnosis of herpes simplex virus infections.

Authors:  Ameeta Singh; Jutta Preiksaitis; Alex Ferenczy; Barbara Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

9.  Viral diseases of the skin: diagnosis and antiviral treatment.

Authors:  Zoltan Trizna
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

10.  Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland.

Authors:  J S Smith; M Rosinska; A Trzcinska; J M Pimenta; B Litwinska; J Siennicka
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.